Helix28 LabsRetatrutide
research, refined.
Professionally documented Retatrutide for qualified research use, with clear batch records, responsive support, and a clean ordering experience.
Retatrutide 10 mg
Primary research compound. Batch-level transparency, professional documentation, quality-first handling.
Focused compounds,
documented.
Retatrutide remains the flagship focus of Helix28 Labs, with Tirzepatide, GHK-Cu, Tesamorelin, and MOTS-c options presented for qualified research inquiries as availability develops.
Retatrutide 10 mg, for qualified research use.
Retatrutide is the primary research compound featured by Helix28 Labs. Each inquiry is handled with professionalism, clear documentation, and a quality-first release process designed for serious research environments.
Research compound profile
Current product information includes research-use handling, availability, and batch documentation. Contact Helix28 Labs for current lot status before ordering.
| Compound | Retatrutide |
|---|---|
| CAS | 2381089-83-2 |
| Size | 10 mg |
| Documentation | COA available |
| Lot / Batch | RET-10-0726 |
One flagship compound,
fully documented.
Retatrutide 10 mg with batch-level identity, a certificate of analysis per released lot, and cold-chain packaging available on request.
Clarity before the order
Retatrutide-first
The site, documentation, and ordering flow are centered around Retatrutide research inquiries rather than a broad supplement-style catalog.
Documentation-forward
COA access, batch identifiers, and professional support give visitors the information they need before placing an order.
Direct order support
Order questions, batch availability, shipping details, and documentation requests are handled through a direct lab support channel.
Controls, not claims
Clear sourcing expectations, batch-level documentation, and careful handling from inquiry through fulfillment.
Identity documentation
Retatrutide lots are presented with batch-level identity and documentation details for qualified research review.
Purity transparency
Purity is documented per released lot on its certificate of analysis. Read the certificate, not a claim.
Professional handling
Storage, labeling, communication, and fulfillment details are kept organized for a premium research-client experience.
Documented.
Not claimed.
Every released lot carries its certificate. Read the record, not the promise.
Read the certificate.
Separate COA downloads for each research compound. Updated batch certificates are added as new lots are released.
Current lot summary
| Method | HPLC / MS |
|---|---|
| Target purity | Product-specific |
| Release status | Available |
| Lot / Batch | RET-10-0726 |
Before you order.
Are Retatrutide and Tirzepatide for research use only?
Yes. Every product is sold strictly for lawful laboratory research use. Not for human consumption, and not for clinical, diagnostic, therapeutic, or veterinary use.
Do Retatrutide and Tirzepatide include COA documentation?
Yes. Each released lot carries its own certificate of analysis, referenced by lot number. See the COAs page for current documentation.
Which product is the primary focus?
Retatrutide is the flagship focus. Tirzepatide, GHK-Cu, Tesamorelin, and MOTS-c are additional options for qualified research inquiries as availability develops.
How do I view or order a product?
Open the catalog, choose a compound, and order directly, or start with an inquiry to orders@helix28labs.store for availability and documentation first.
Ready to order with confidence?
Start with a direct inquiry. We will help with availability, batch documentation, COA access, shipping questions, and next steps for qualified research use, from El Paso, Texas.